FunMedDev: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FunMedDev
Largest movements
- Receivables within one year +€48,739
up €48,739 (+284.5%), from €17,133 to €65,872
of which Trade receivables: +€48,920
- Cash +€38,078
up €38,078 (+653.4%), from €5,828 to €43,906
mainly Trade debts (+€65,614) and Net result for the year (+€35,027)
- Deferred charges and accrued income +€22,716
up €22,716 (+384.7%), from €5,905 to €28,621
- Trade debts +€65,614
up €65,614 (+382.0%), from €17,178 to €82,792
- Profit (loss) carried forward +€35,027
up €35,027, from -€25,529 to €9,498
- Tax, wage and social debts +€7,917
up €7,917 (+24.6%), from €32,216 to €40,133
of which Taxes: +€4,199
- Gross operating margin +€107,382
up €107,382 (+96.2%), from €111,578 to €218,961
- Staff costs +€35,975
up €35,975 (+24.8%), from €145,023 to €180,998
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €28,865 | €138,399 | +€109,533 | +379.5% |
| Current assets | 29/58 | €28,865 | €138,399 | +€109,533 | +379.5% |
| Amounts receivable within one year | 40/41 | €17,133 | €65,872 | +€48,739 | +284.5% |
| Trade receivables | 40 | €16,300 | €65,220 | +€48,920 | +300.1% |
| Other amounts receivable | 41 | €833 | €652 | -€181 | -21.7% |
| Cash at bank and in hand | 54/58 | €5,828 | €43,906 | +€38,078 | +653.4% |
| Deferred charges and accrued income | 490/1 | €5,905 | €28,621 | +€22,716 | +384.7% |
| Total equity and liabilities | 10/49 | €28,865 | €138,399 | +€109,533 | +379.5% |
| Equity | 10/15 | -€22,529 | €12,498 | +€35,027 | |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€25,529 | €9,498 | +€35,027 | |
| Amounts payable | 17/49 | €51,394 | €125,900 | +€74,506 | +145.0% |
| Amounts payable within one year | 42/48 | €51,394 | €125,900 | +€74,506 | +145.0% |
| Trade debts | 44 | €17,178 | €82,792 | +€65,614 | +382.0% |
| Suppliers | 440/4 | €17,178 | €82,792 | +€65,614 | +382.0% |
| Taxes, remuneration and social security | 45 | €32,216 | €40,133 | +€7,917 | +24.6% |
| Taxes | 450/3 | €5,572 | €9,771 | +€4,199 | +75.4% |
| Remuneration and social security | 454/9 | €26,644 | €30,362 | +€3,718 | +14.0% |
| Other amounts payable | 47/48 | €2,000 | €2,976 | +€975 | +48.8% |
| Remuneration, social security and pensions | 62 | €145,023 | €180,998 | +€35,975 | +24.8% |
| Other operating charges | 640/8 | €359 | €465 | +€106 | +29.6% |
| Gross operating margin | 9900 | €111,578 | €218,961 | +€107,382 | +96.2% |
| Operating profit (loss) | 9901 | -€33,804 | €37,497 | +€71,301 | |
| Financial income | 75/76B | - | €29 | +€29 | |
| Recurring financial income | 75 | - | €29 | +€29 | |
| Financial charges | 65/66B | €297 | €609 | +€312 | +105.1% |
| Recurring financial charges | 65 | €297 | €609 | +€312 | +105.1% |
| Profit (loss) for the period before taxes | 9903 | -€34,100 | €36,917 | +€71,018 | |
| Income taxes | 67/77 | - | €1,891 | +€1,891 | |
| Profit (loss) for the period | 9904 | -€34,100 | €35,027 | +€69,127 | |
| Profit (loss) for the period to be appropriated | 9905 | -€34,100 | €35,027 | +€69,127 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.